SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-031531
Filing Date
2022-03-08
Accepted
2022-03-08 16:16:01
Documents
14
Period of Report
2022-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228500d1_8k.htm   iXBRL 8-K 33134
2 EXHIBIT 4.1 tm228500d1_ex4-1.htm EX-4.1 72476
3 EXHIBIT 99.1 tm228500d1_ex99-1.htm EX-99.1 602580
  Complete submission text file 0001104659-22-031531.txt   1019343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbio-20220304.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20220304_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20220304_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT tm228500d1_8k_htm.xml XML 3596
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 22721943
SIC: 2834 Pharmaceutical Preparations